Pre Clinical Safety and Toxicology

Services for Preclinical Safety and Toxicity testing stage

• Ontomine - Computational bioactivity, adverse effect and toxicology prediction and screening
• In vitro safety, cell viability, apoptosis and cytotoxicity
• In vitro genotoxicity
• In vivo toxicology
• In vivo safety, ICH Core Battery
• Cardiovascular safety
• Gastro-intestinal safety
• Central nervous system safety
• Respiratorial safety
• Metabolites in safety testing (MIST)
• Regulatory guidance

Other expertise areas

• SBW Solutions
• SBW-Alpha - Target Discovery
• SBW-Beta - Hit screening
• SBW-Gamma - Hits to leads
• SBW-Delta - Lead optimization
• SBW-Epsilon - Pre clinical
• SBW- Zeta - Clinical development phases 1-2
• SBW- Eta - Clinical development phases 3-4
• Food industry
• Chemical industry, REACH

We provide comprehensive activities in the safety and toxicology testing areas, tailored for the needs of the different industries

• In silico prediction of the molecules toxicity and adverse effects
• In vitro safety, including cytotoxity, cell viability and apoptosis testing
• In vitro genotoxicity testing
• In vivo safety testing
• In vivo early tox screening, MTD and repeated dose toxicity testing

We operate in many of these areas both in non-GLP as well as in GLP settings, depending on the customers needs. In addition, we provide our customers with consultation related to toxicology and safety testing in various industry areas.

For more information, contact us from this link.

All our services are tailored per customers need. Our business models includes variations from fee for service / FTE to strategic business process outsourcing and partnership. Please see this page for our business models and here for an overview of our various solutions areas.